Browsing Tag
Wedbush
8 posts
Nasdaq-100 in 5 days, S&P 500 blocked until 2027: what SpaceX (SPCX) is still missing
Wedbush initiates SpaceX (SPCX) at Outperform, $190 target, $2.5T enterprise value; Nasdaq-100 inclusion July 7 adds $4.3B in passive inflows. Winners named.
Abivax (NASDAQ: ABVX) obefazimod NDA path meets a safety debate the market is still pricing
Abivax (NASDAQ: ABVX) put up Rinvoq-like ulcerative colitis remission data and dropped 40 percent. The question is whether the malignancy debate sticks.
Innodata’s new CFO inherits a booming AI business and a valuation with little room for error
Innodata names Jayant Chauhan CFO as AI growth accelerates. See how finance discipline, M&A expertise and valuation pressure could shape its next phase now.
US officials discuss taking equity stakes in major AI companies, following the Intel precedent
US officials have held preliminary talks with major AI firms about government equity stakes, following the Intel precedent. Wedbush calls voluntary stakes manageable.
Planet Labs (NYSE: PL) crashes 25% after a record quarter and a 400% run
Planet Labs (NYSE: PL) posted record revenue and big defense wins, then fell 25%. After a 400% run, expectations, not results, became the problem.
Tango Therapeutics (NASDAQ: TNGX) jumps 11% into May 11 earnings and pivotal pancreatic cancer data
Tango Therapeutics is up 22-fold from $1.04 in twelve months. The May 11 earnings print decides whether vopimetostat justifies the run or breaks it.
Rivian (RIVN) R2 launch and Uber robotaxi deal put 2026 at the centre of the EV turnaround story
Rivian (NASDAQ: RIVN) is launching the R2 SUV, closing a USD 1.25B Uber robotaxi deal, and receiving fresh VW funding. Here is what retail investors need to know.
IBM and ElevenLabs bring enterprise-grade voice AI to watsonx Orchestrate, targeting regulated sectors at scale
IBM integrates ElevenLabs voice AI into watsonx Orchestrate with HIPAA and PCI controls, targeting healthcare, banking, and government. Read the full analysis.